Over the trailing 12 months, CING insiders bought $166,693 worth of shares (33.07K shares) in open-market trades, with no open-market sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Peter J. Werth | Director | 0 | 117,449 | 117,449 | 77.0% | 10 Feb, 2026 |
| 2 | Jennifer L. Callahan | Evp And Cfo | 13,961 | 0 | 13,961 | 9.2% | 11 Mar, 2026 |
| 3 | Matthew Brams | Evp And Chief Medical Officer | 8,157 | 0 | 8,157 | 5.3% | 11 Mar, 2026 |
| 4 | Raul R. Silva | Evp And Cso | 4,645 | 0 | 4,645 | 3.0% | 11 Mar, 2026 |
| 5 | Shane J. Schaffer | Chief Executive Officer | 4,076 | 0 | 4,076 | 2.7% | 11 Mar, 2026 |
| 6 | Nilay Dahyabhai Patel | Evp, Clo And Cco | 3,389 | 0 | 3,389 | 2.2% | 11 Mar, 2026 |
| 7 | Gregg Wm Givens | Director | 643 | 0 | 643 | 0.4% | 25 Nov, 2022 |
| 8 | Curtis Medeiros | Director | 73 | 0 | 73 | 0.0% | 16 Mar, 2022 |
| 9 | Horn Louis G Van | Evp And Cfo | 63 | 0 | 63 | 0.0% | 16 Mar, 2022 |
| 10 | Craig S. Gilgallon | Evp, Gc And Secretary | 40 | 0 | 40 | 0.0% | 28 Nov, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 30 Sep, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 4,293 | $0.00 | $0 | 4,293 | Direct |
| 16 Jul, 2026 | Matthew Brams | Evp And Chief Medical Officer | Acquired A | 53,600 | $0.00 | $0 | 53,600 | Direct |
| 16 Jul, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 53,600 | $0.00 | $0 | 53,600 | Direct |
| 16 Jul, 2026 | Peter J. Werth | Director | Acquired A | 20,000 | $0.00 | $0 | 20,000 | Direct |
| 16 Jul, 2026 | Thomas Jeffrey Hargroves | Director | Acquired A | 20,000 | $0.00 | $0 | 20,000 | Direct |
| 16 Jul, 2026 | Bryan Jay Lawrence | Director | Acquired A | 20,000 | $0.00 | $0 | 20,000 | Direct |
| 16 Jul, 2026 | Bryan Wade Downey | Evp Chief Commercial Officer | Acquired A | 67,000 | $0.00 | $0 | 67,000 | Direct |
| 16 Jul, 2026 | Jennifer L. Callahan | Evp And Cfo | Acquired A | 40,200 | $0.00 | $0 | 40,200 | Direct |
| 16 Jul, 2026 | Shane J. Schaffer | Chief Executive Officer | Acquired A | 197,650 | $0.00 | $0 | 197,650 | Direct |
| 16 Jul, 2026 | Bryan Wade Downey | Evp Chief Commercial Officer | Acquired A | 33,000 | $0.00 | $0 | 33,000 | Direct |
| 16 Jul, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 26,400 | $0.00 | $0 | 26,400 | Direct |
| 16 Jul, 2026 | Matthew Brams | Evp And Chief Medical Officer | Acquired A | 26,400 | $0.00 | $0 | 26,400 | Direct |
| 16 Jul, 2026 | Shane J. Schaffer | Chief Executive Officer | Acquired A | 97,350 | $0.00 | $0 | 97,350 | Direct |
| 16 Jul, 2026 | Jennifer L. Callahan | Evp And Cfo | Acquired A | 19,800 | $0.00 | $0 | 19,800 | Direct |
| 30 Jun, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 3,885 | $0.00 | $0 | 3,885 | Direct |
| 31 Mar, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 3,422 | $0.00 | $0 | 3 | Direct |
| 09 Mar, 2026 | Nilay Dahyabhai Patel | Evp, Clo And Cco | Acquired A | 5,475 | $0.00 | $0 | 5,475 | Direct |
| 09 Mar, 2026 | Raul R. Silva | Evp And Cso | Acquired A | 4,526 | $0.00 | $0 | 6,473 | Direct |
| 09 Mar, 2026 | Shane J. Schaffer | Chief Executive Officer | Acquired A | 6,862 | $0.00 | $0 | 7,035 | Direct |
| 09 Mar, 2026 | Jennifer L. Callahan | Evp And Cfo | Acquired A | 15,329 | $0.00 | $0 | 20,388 | Direct |